168 related articles for article (PubMed ID: 20019695)
21. ABC-transporters as stem-cell markers in brain dysplasia/tumor epilepsies.
Czornyj L; Lazarowski A
Front Biosci (Landmark Ed); 2014 Jun; 19(8):1425-35. PubMed ID: 24896362
[TBL] [Abstract][Full Text] [Related]
22. The potential of pharmacogenetics in the treatment of epilepsy.
Depondt C
Eur J Paediatr Neurol; 2006 Mar; 10(2):57-65. PubMed ID: 16531088
[TBL] [Abstract][Full Text] [Related]
23. [Impact of pharmacogenetics on the drug therapy of epilepsy].
Zang LL; Wang L; Wu Y
Zhonghua Er Ke Za Zhi; 2011 Aug; 49(8):599-602. PubMed ID: 22093423
[No Abstract] [Full Text] [Related]
24. Pharmacogenomic importance of ABCG2.
Cusatis G; Sparreboom A
Pharmacogenomics; 2008 Aug; 9(8):1005-9. PubMed ID: 18681776
[TBL] [Abstract][Full Text] [Related]
25. A systematic review and meta-analysis of the role of ABCC2 variants on drug response in patients with epilepsy.
Grover S; Kukreti R
Epilepsia; 2013 May; 54(5):936-45. PubMed ID: 23506516
[TBL] [Abstract][Full Text] [Related]
26. The intrinsic severity hypothesis of pharmacoresistance to antiepileptic drugs.
Rogawski MA
Epilepsia; 2013 May; 54 Suppl 2():33-40. PubMed ID: 23646969
[TBL] [Abstract][Full Text] [Related]
27. Association of polymorphisms of CYP2C9, CYP2C19, and ABCB1, and activity of P-glycoprotein with response to anti-epileptic drugs.
Taur SR; Kulkarni NB; Gandhe PP; Thelma BK; Ravat SH; Gogtay NJ; Thatte UM
J Postgrad Med; 2014; 60(3):265-9. PubMed ID: 25121365
[TBL] [Abstract][Full Text] [Related]
28. Ontogeny of ABC and SLC transporters in the microvessels of developing rat brain.
Soares RV; Do TM; Mabondzo A; Pons G; Chhun S
Fundam Clin Pharmacol; 2016 Apr; 30(2):107-16. PubMed ID: 26662930
[TBL] [Abstract][Full Text] [Related]
29. Closed-loop Neuropharmacology for Epilepsy: Distant Dream or Future Reality?
Aicua-Rapun I; André P; Novy J
Curr Neuropharmacol; 2019; 17(5):447-458. PubMed ID: 29521237
[TBL] [Abstract][Full Text] [Related]
30. Pharmacogenomics in epilepsy.
Balestrini S; Sisodiya SM
Neurosci Lett; 2018 Feb; 667():27-39. PubMed ID: 28082152
[TBL] [Abstract][Full Text] [Related]
31. Role of pharmacogenetics of ATP-binding cassette transporters in the pharmacokinetics of drugs.
Cascorbi I
Pharmacol Ther; 2006 Nov; 112(2):457-73. PubMed ID: 16766035
[TBL] [Abstract][Full Text] [Related]
32. Clinical factors and ABCB1 polymorphisms in prediction of antiepileptic drug response: a prospective cohort study.
Leschziner G; Jorgensen AL; Andrew T; Pirmohamed M; Williamson PR; Marson AG; Coffey AJ; Middleditch C; Rogers J; Bentley DR; Chadwick DW; Balding DJ; Johnson MR
Lancet Neurol; 2006 Aug; 5(8):668-76. PubMed ID: 16857572
[TBL] [Abstract][Full Text] [Related]
33. Epilepsy pharmacogenetics.
Kasperaviciūte D; Sisodiya SM
Pharmacogenomics; 2009 May; 10(5):817-36. PubMed ID: 19450130
[TBL] [Abstract][Full Text] [Related]
34. [Drug resistance in partial epilepsy: epidemiology, mechanisms, pharmacogenetics and therapeutical aspects].
Mann MW; Pons G
Neurochirurgie; 2008 May; 54(3):259-64. PubMed ID: 18417170
[TBL] [Abstract][Full Text] [Related]
35. The relationship between the pharmacology of antiepileptic drugs and human gene variation: an overview.
Ferraro TN; Buono RJ
Epilepsy Behav; 2005 Aug; 7(1):18-36. PubMed ID: 15979945
[TBL] [Abstract][Full Text] [Related]
36. Lack of association between the C3435T polymorphism in the human multidrug resistance (MDR1) gene and response to antiepileptic drug treatment.
Basic S; Hajnsek S; Poljakovic Z; Basic M
Epilepsia; 2006 Feb; 47(2):449; author reply 450. PubMed ID: 16499776
[No Abstract] [Full Text] [Related]
37. Refractory epilepsy: clinical overview.
French JA
Epilepsia; 2007; 48 Suppl 1():3-7. PubMed ID: 17316406
[TBL] [Abstract][Full Text] [Related]
38. Intestinal expression of cytochrome P450 enzymes and ABC transporters and carbamazepine and phenytoin disposition.
Simon C; Stieger B; Kullak-Ublick GA; Fried M; Mueller S; Fritschy JM; Wieser HG; Pauli-Magnus C
Acta Neurol Scand; 2007 Apr; 115(4):232-42. PubMed ID: 17376120
[TBL] [Abstract][Full Text] [Related]
39. ATP-binding cassette transmembrane transporters and their epigenetic control in cancer: an overview.
Arrigoni E; Galimberti S; Petrini M; Danesi R; Di Paolo A
Expert Opin Drug Metab Toxicol; 2016 Dec; 12(12):1419-1432. PubMed ID: 27459275
[TBL] [Abstract][Full Text] [Related]
40. [Pharmacogenetic criteria of drug-resistant epilepsy].
Oros MM
Lik Sprava; 2012 Dec; (8):71-4. PubMed ID: 23786015
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
